Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

approved   publishing date : 2022 - 03 - 30    save search

GFG Receives TSXV Conditional Approval for Acquisition of WWCC Gold Property
Published: 2022-03-30 (Crawled : 22:00) - globenewswire.com
GFGSF | $0.0628 96.25% 90K twitter stocktwits trandingview |
n/a
| | O: 0.07% H: 0.0% C: 0.0%

acquisition approval
Shockwave Medical Announces Japanese Regulatory Approval of Coronary IVL
Published: 2022-03-30 (Crawled : 16:00) - biospace.com/
SWAV | $328.56 0.01% 0.01% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.29% H: 2.33% C: -0.79%

approval
Thermo Fisher Scientific’s PPD Clinical Research Business Earns TOPRA Award for Regulatory Affairs Excellence in Supporting Novavax’s COVID-19 Vaccine Approval
Published: 2022-03-30 (Crawled : 14:00) - biospace.com/
TMO | News | $577.39 0.49% 0.0% 2M twitter stocktwits trandingview |
Health Technology
| | O: 0.29% H: 0.0% C: 0.0%

covid-19 research vaccine approval
NanoVibronix Announces PainGuard and UroGuard Approved by Health Canada as Licensed Medical Devices
Published: 2022-03-30 (Crawled : 13:00) - biospace.com/
NAOV 4 | $0.77 -5.68% 8.6K twitter stocktwits trandingview |
Health Technology
| | O: 24.85% H: 20.35% C: -1.77%

health painguard uroguard license
PARTNER COMMUNICATIONS ANNOUNCES THE RECEIPT OF THE MINISTRY OF COMMUNICATIONS' APPROVAL WITH RESPECT TO A TRANSACTION TO SELL THE COMPANY'S SHARES UNDER RECEIVERSHIP
Published: 2022-03-30 (Crawled : 09:00) - prnewswire.com
PTNR | $6.61 0.0% 0 twitter stocktwits trandingview |
Communications
| | O: 0.59% H: 0.0% C: -3.86%

approval communications
Antengene Announces IND Approval in China for a Phase II Study of Eltanexor (ATG-016) in Patients with High-Risk Myelodysplastic Syndromes
Published: 2022-03-30 (Crawled : 02:00) - prnewswire.com
KPTI | $1.1 0.92% 0.91% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.91% H: 4.06% C: -3.8%

atg-016 approval china
U.S. FDA Approves CABENUVA (cabotegravir and rilpivirine) for Adolescents, Expanding the Indication of the First and Only Complete Long-Acting Injectable HIV Regimen
Published: 2022-03-30 (Crawled : 01:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.18% H: 0.0% C: 0.0%

fda hiv
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.